Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 261
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Tramcoat 40 mg V/DCP/24/0013 Alfasan Nederland BV, Nīderlande QN02AX02 dogs

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0013-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0013-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramcoat 20 mg V/DCP/24/0012 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0012-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0012-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tramcoat 8 mg V/DCP/24/0011 Alfasan Nederland BV, Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Alfasan Nederland BV, Nīderlande;Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 02-Feb-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (02-Feb-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (02-Feb-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0011-01 1 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-02 2 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-03 3 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-04 4 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-05 5 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-06 6 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-07 7 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-08 8 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-09 9 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-10 10 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-11 12 PVH/PE/PVDH-Al blisteris, 10 tablete -
V/DCP/24/0011-12 25 PVH/PE/PVDH-Al blisteris, 10 tablete -
Tralieve vet 20 mg V/DCP/18/0024 Dechra Regulatory B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0024-01 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-02 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-03 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-04 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-05 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-06 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-07 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-08 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-09 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-10 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-11 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0024-12 30 PVDH/PE/PVH/Al blisteris, 10 tablete -
Tralieve vet 80 mg V/DCP/18/0025 Dechra Regulatory B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande;GENERA Inc., Horvātija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (21-Nov-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (21-Nov-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/18/0025-01 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-02 2 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-03 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-04 4 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-05 5 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-06 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-07 7 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-08 8 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-09 9 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-10 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-11 25 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/18/0025-12 30 PVDH/PE/PVH/Al blisteris, 10 tablete -
Tralieve Vet 50 mg/ml V/DCP/19/0008 Le Vet Beheer B.V., Nīderlande QN02AX02 dogs Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tramadol hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Produlab Pharma b.v., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (07-Oct-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (07-Oct-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/19/0008-01 50 mg/ml 1 Stikla flakons, 10 ml -
V/DCP/19/0008-02 50 mg/ml 1 Stikla flakons, 20 ml -
V/DCP/19/0008-03 50 mg/ml 1 Stikla flakons, 50 ml -
V/DCP/19/0008-04 50 mg/ml 6 Stikla flakons, 10 ml -
V/DCP/19/0008-05 50 mg/ml 6 Stikla flakons, 20 ml -
V/DCP/19/0008-06 50 mg/ml 6 Stikla flakons, 50 ml -
V/DCP/19/0008-07 50 mg/ml 10 Stikla flakons, 10 ml -
V/DCP/19/0008-08 50 mg/ml 10 Stikla flakons, 20 ml -
V/DCP/19/0008-09 50 mg/ml 10 Stikla flakons, 50 ml -
Topimec F - V/MRP/21/0072 Chanelle Pharmaceuticals Manufacturing Limited, Īrija QP54AA51 cattle Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Ivermectin, Clorsulon
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Limited, Īrija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOCX] 29112021LI (29-Nov-2021)
Labelling text: [DOCX] 29112021M (29-Nov-2021)
Summary of product characteristics: [DOCX] 29112021ZA (29-Nov-2021)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/21/0072-01 1 ABPE pudele, 50 ml -
V/MRP/21/0072-02 1 ABPE pudele, 250 ml -
V/MRP/21/0072-03 1 ABPE pudele, 500 ml -
Eprizero 5 mg/ml V/DCP/13/0008 Norbrook Laboratories (Ireland) Limited, Īrija QP54AA04 cattle Vairāk

Medicinal product information

Pharmaceutical form: Pour-on solution
International name (active substance): Eprinomectin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Norbrook Laboratories Limited, Lielbritānija;Norbrook Manufacturing Limited, Īrija
Date of authorisation/renewal: 10-May-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (27-Jan-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (27-Jan-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/13/0008-01 5 mg/ml 1 ABPE konteiners (caurspīdīgs), 250 ml -
V/DCP/13/0008-02 5 mg/ml 1 ABPE konteiners (caurspīdīgs), 1000 ml -
V/DCP/13/0008-03 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 1 l -
V/DCP/13/0008-04 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 2,5 l -
V/DCP/13/0008-05 5 mg/ml 1 ABPE mugursomas tipa konteiners (balts), 5 l -
Antisedan Vet 5 mg/ml V/NRP/02/1452 Orion Corporation, Somija QV03AB90 dogs; cats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Atipamezole hydrochloride
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Orion Corporation Orion Pharma, Somija
Date of authorisation/renewal: 06-Jun-2012
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 27102022LI (16-Nov-2023)
Labelling text: [PDF] 171218M (16-Nov-2023)
Summary of product characteristics: [DOCX] 250320ZA (16-Nov-2023)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/02/1452-01 5 mg/ml 1 Stikla flakons, 10 ml [PDF] [JPG]
Parofor 140 mg/ml V/DCP/17/0035 Huvepharma NV, Beļģija QA07AA06 pigs; pre-ruminant cattle Vairāk

Medicinal product information

Pharmaceutical form: Solution for use in drinking water/milk
International name (active substance): Paromomycin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Biovet Joint Stock Company., Bulgārija
Date of authorisation/renewal: 28-Jun-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (26-Feb-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (26-Feb-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/17/0035-01 140 mg/ml 1 ABPE pudele, 125 ml -
V/DCP/17/0035-02 140 mg/ml 1 ABPE pudele, 250 ml -
V/DCP/17/0035-03 140 mg/ml 1 ABPE pudele, 500 ml -
V/DCP/17/0035-04 140 mg/ml 1 ABPE pudele, 1000 ml -
C-B-Gluconat 24% plus 6% - V/NRP/14/0004 Bela-pharm GmbH&Co.KG, Vācija QA12AX cattle; pigs; sheep; goats; horses Vairāk

Medicinal product information

Pharmaceutical form: solution for infusion
International name (active substance): Boric Acid,Calcium gluconate,Magnesium chloride hexahydrate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Bela-pharm GmbH&Co.KG, Vācija
Date of authorisation/renewal: 28-Dec-2018
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (09-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (09-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/14/0004-01 1 Polipropilēna pudele, 500 ml [JPG] [JPG] [JPG] [PDF]
V/NRP/14/0004-02 6 Polipropilēna pudele, 500 ml -
V/NRP/14/0004-03 12 Polipropilēna pudele, 500 ml -
LV Calmasol-440 - V/NRP/19/0003 SIA "Vetmarket", Latvija QA12AX cattle; pigs; sheep Vairāk

Medicinal product information

Pharmaceutical form: solution for infusion
International name (active substance): Calcium gluconate, Magnesium chloride hexahydrate, Boric Acid
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 020419_LI (04-Apr-2019)
Labelling text: [PDF] 020419_M (04-Apr-2019)
Summary of product characteristics: [PDF] 020419_ZA (04-Apr-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/19/0003-01 1 Plastmasas pudele, 500 ml -
LV Colisol Oral 2000000 IU/ml V/NRP/19/0024 SIA "Vetmarket", Latvija QA07AA10 pigs; chickens Vairāk

Medicinal product information

Pharmaceutical form: concentrate for oral solution
International name (active substance): Colistin sulfate
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Interchemie Werken De Adelaar Eesti AS, Igaunija
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [PDF] 04062019_LI (04-Jun-2019)
Labelling text: [PDF] 04062019_M (04-Jun-2019)
Summary of product characteristics: [PDF] 04062019_ZA (04-Jun-2019)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/19/0024-01 2000000 mg/ml 1 ABPE pudele, 1000 ml -
Dophasin 200000 IU/ml V/DCP/24/0032 Dopharma Research B.V., Nīderlande QJ01FA90 cattle; pigs; sheep; goats Vairāk

Medicinal product information

Pharmaceutical form: solution for injection
International name (active substance): Tylosin
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Dopharma B.V., Nīderlande
Date of authorisation/renewal: 30-Apr-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (13-May-2025)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (13-May-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0032-01 1 Stikla flakons, 100 ml -
V/DCP/24/0032-02 1 Stikla flakons, 50 ml -
Milbemycin oxime / Praziquantel Alfamed 4 mg/10 mg - V/DCP/24/0059 Alfamed, Francija QP54AB51 cats; kittens Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (03-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0059-01 12 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 16 mg/40 mg - V/DCP/24/0060 Alfamed, Francija QP54AB51 cats Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0060-01 24 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 12,5 mg/125 mg - V/DCP/24/0062 Alfamed, Francija QP54AB51 dogs Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0062-01 24 Blisteris, 2 tablete -
Milbemycin oxime / Praziquantel Alfamed 2,5 mg/25 mg - V/DCP/24/0061 Alfamed, Francija QP54AB51 dogs; puppies Vairāk

Medicinal product information

Pharmaceutical form: film-coated tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release VIRBAC, Francija;Alfamed, Francija
Date of authorisation/renewal: 04-Sep-2024
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (04-Sep-2024)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (04-Sep-2024)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/24/0061-01 12 Blisteris, 2 tablete -
Prazitel Plus XL - V/MRP/12/0061 Chanelle Pharmaceuticals Manufacturing Ltd., Īrija QP52AA51 dogs Vairāk

Medicinal product information

Pharmaceutical form: tablets
International name (active substance): Febantel,Praziquantel,Pyrantel embonate
Distribution category: Nonprescription veterinary medicinal product
Manufacturer(s) responsible for batch release Chanelle Pharmaceuticals Manufacturing Ltd., Īrija
Date of authorisation/renewal: 31-Jul-2017
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Labelling text: [PDF] Skat_sadaļā_Zāļu_apraksts (30-May-2023)
Summary of product characteristics: [DOCX] Zāļu_informācija_ZA_M_LI (31-Jul-2025)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/12/0061-01 1 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-02 1 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-03 1 PVH/PE/PHTFE/alumīnija blisteris, 5 tablete -
V/MRP/12/0061-04 1 PVH/PE/PHTFE/alumīnija blisteris, 6 tablete -
V/MRP/12/0061-05 1 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-06 1 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-07 1 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-08 1 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-09 1 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-10 1 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-11 1 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-12 2 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-13 2 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-14 3 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-15 2 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-16 2 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-17 2 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-18 21 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-19 11 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-20 3 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-21 5 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-22 13 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-23 4 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-24 3 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-25 4 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-26 17 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-27 5 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-28 4 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-29 19 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-30 4 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-31 6 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-32 11 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-33 23 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-34 6 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-35 7 PVH/PE/PHTFE/alumīnija blisteris, 14 tablete -
V/MRP/12/0061-36 5 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-37 13 PVH/PE/PHTFE/alumīnija blisteris, 8 tablete -
V/MRP/12/0061-38 53 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-39 6 PVH/PE/PHTFE/alumīnija blisteris, 18 tablete -
V/MRP/12/0061-40 7 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-41 29 PVH/PE/PHTFE/alumīnija blisteris, 4 tablete -
V/MRP/12/0061-42 6 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-43 7 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-44 15 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-45 9 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-46 10 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-47 17 PVH/PE/PHTFE/alumīnija blisteris, 12 tablete -
V/MRP/12/0061-48 103 PVH/PE/PHTFE/alumīnija blisteris, 2 tablete -
V/MRP/12/0061-49 13 PVH/PE/PHTFE/alumīnija blisteris, 16 tablete -
V/MRP/12/0061-50 25 PVH/PE/PHTFE/alumīnija blisteris, 10 tablete -
V/MRP/12/0061-51 14 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-52 15 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-53 25 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
V/MRP/12/0061-54 50 PVH/PE/PHTFE/alumīnija blisteris, 20 tablete -
Amcofen 2,5 mg/25 mg - V/MRP/19/0013 KRKA, d.d., Novo mesto, Slovēnija QP54AB51 small dogs; puppies weighing at least 0.5 kg Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Milbemycin oxime, Praziquantel
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release KRKA d.d. Novo Mesto, Slovēnija
Date of authorisation/renewal: 02-May-2019
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: MRP
Package leaflet: [DOC] 12012024LI (12-Jan-2024)
Labelling text: [PDF] 02052019M (02-May-2019)
Summary of product characteristics: [DOC] 120122024ZA (12-Jan-2024)

Products

ID Strength Package size Primary packaging Labelling
V/MRP/19/0013-01 2,5/25 mg 2 Al/OPA/Al/PVH blisteris, 2 tablete -
V/MRP/19/0013-02 2,5/25 mg 4 Al/OPA/Al/PVH blisteris, 4 tablete -
V/MRP/19/0013-03 2,5/25 mg 48 Al/OPA/Al/PVH blisteris, 4 tablete -

3082 records

© Food and veterinary service · 2026 Cookies policy